Market Focus: British American Tobacco Stock Performance Analysis

Feb.03
Market Focus: British American Tobacco Stock Performance Analysis
British American Tobacco's stock performance draws market attention, with forecasts suggesting steady growth despite challenges.

According to a report by Finanztrends on February 2nd, the stock performance of British American Tobacco is drawing attention from the market. According to the German financial trends website (finanztrends.de) on February 3rd, British American Tobacco's stock has shown a fluctuating upward trend over the past six months, closing at 38.16 euros at the end of this week, up approximately 17% since August.


At the analyst level, expectations for the stock price of British American Tobacco are gradually improving. According to data from the market analysis firm MarketScreener, there are currently six institutions giving British American Tobacco a "buy" rating, three institutions maintaining a "neutral" rating, and only one institution giving a "sell" rating. Recently, UBS has upgraded its rating on British American Tobacco from neutral to "buy", while Deutsche Bank has also reaffirmed its "buy" rating. Analysts generally believe that British American Tobacco's performance is meeting expectations and anticipate that its stock price will continue to see moderate growth.


According to price targets, the average target price for British American Tobacco has been raised to £33.35 (approximately €39.6), with some institutions even setting a high target of £44 (approximately €52.4). While the overall expectations are not particularly aggressive, analysts generally believe that British American Tobacco's stock price is expected to remain stable, and its stable dividend yield also makes it an attractive investment option for investors.


Despite the relatively optimistic outlook on British American Tobacco in the market, the company still faces some challenges. The decline in traditional tobacco business and uncertainty in emerging sectors such as e-cigarettes may have an impact on its performance. However, based on current market performance, British American Tobacco seems to have gradually recovered from its low point in 2023, reaching its highest stock price in nearly two years. Nevertheless, whether the company can achieve a better balance between traditional tobacco business and emerging sectors in the future remains to be seen.


Original text: British American Tobacco-Aktie: Im Rahmen der Erwartungen! Translation: British American Tobacco stock: In line with expectations!


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Singapore May Tighten E-Cigarette Rules as Surge Detected in Products Laced with Anesthetic Etomidate
Singapore May Tighten E-Cigarette Rules as Surge Detected in Products Laced with Anesthetic Etomidate
Singapore plans to tighten vaping laws after detecting 28 etomidate-laced e-cigarette cases in H1 2025—nearly triple 2024’s total. Despite the 2018 ban, S$41 million worth of products were seized from Jan 2024 to Mar 2025, and a UN report shows rising etomidate e-cigarette use across East and Southeast Asia.
Jul.15 by 2FIRSTS.ai
BAT's Vuse Ultra Vape Launches in UK Brick-and-Mortar Retail, Initially Rolling Out to Around 2,000 Stores
BAT's Vuse Ultra Vape Launches in UK Brick-and-Mortar Retail, Initially Rolling Out to Around 2,000 Stores
Vuse, British American Tobacco’s vaping brand, has officially rolled out its new product—Vuse Ultra—into UK convenience stores. The initial launch covers about 2,000 retail outlets and offers four flavors. The device retails for £30, while a two-pod pack is priced at £9.
Aug.06 by 2FIRSTS.ai
Ireland Finds "Nicotine-Free" E-Cigarettes Contain Nicotine; Involves McKesse, JNR, and Crystal Brands
Ireland Finds "Nicotine-Free" E-Cigarettes Contain Nicotine; Involves McKesse, JNR, and Crystal Brands
Ireland’s HSE found some “nicotine-free” e-cigarettes contain nicotine, misleading consumers and risking addiction. The products were seized, and a warning issued. Experts warn nicotine addiction is underestimated, and health impacts remain unclear.
Aug.01 by 2FIRSTS.ai
Research Review | Between Harm Reduction and Environmental Care: Innovation, Regulation, and New Environmental Challenges in Argentina and South America
Research Review | Between Harm Reduction and Environmental Care: Innovation, Regulation, and New Environmental Challenges in Argentina and South America
This article is based on research materials provided by an Argentine team and edited by 2Firsts. It reviews the latest developments in South America’s NGP market, covering regulatory differences, environmental challenges, and the balance between harm reduction and sustainability.
Aug.25
Penang, Malaysia, pushes forward with anti-smoking bill; 2,647 fines issued as of August
Penang, Malaysia, pushes forward with anti-smoking bill; 2,647 fines issued as of August
Some businesses in Penang, Malaysia have until September 30 to comply with the Public Health (Control of Tobacco Products) Regulations 2024.
Aug.08 by 2FIRSTS.ai
Philippine Health Department Teams Up with High School Students in Anti-Vaping Campaign
Philippine Health Department Teams Up with High School Students in Anti-Vaping Campaign
The Philippine Department of Health has partnered with the country's first student-led anti-smoking committee to tackle the surge in youth tobacco and e-cigarette use. The campus-based health campaign focuses on exposing industry marketing tactics targeting young people.
Jul.01 by 2FIRSTS.ai